Buy Bajaj Consumer Care; target of Rs 760: ICICI Securities
ICICI Securities research report on Bajaj Consumer Care
Bajaj Consumer (BACO) reported Q2FY27 revenue of INR 3,328mn (vs. our estimate of INR 3,310mn), up ~26% YoY, driven by double-digit (in-line) unit volume growth in Almond Drops Hair Oil (ADHO). EBITDA margin expanded 670bps YoY to 24.7% (ahead of our estimate), primarily aided by lower A&SP spends at 12.5% of sales (vs. 14.7% in Q2FY26). The company remains net-debt-free, providing flexibility to fund distribution and brand investment. We retain our constructive view on BACO, supported by healthy growth momentum in ADHO and non-ADHO portfolios and Aarohan 2.0-led retail expansion and productivity gains. Key monitorables are outlet additions, productivity in existing markets, new product scale-up, raw material (RM) costs and ad spends. Reiterate BUY.
Outlook
We broadly maintain our estimates for FY27/28 and model revenue/EBITDA/PAT CAGR of 16%/33%/33% over FY26-28E, respectively. Maintain BUY with a DCF-based unchanged target price of INR 760. Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions. Bajaj Consumer Care - 1610026 - icici